Case-only designs for studying the association of antidepressants and hip or femur fracture

Publication date

2016-03-01

Authors

De Groot, Mark C. H.ORCID 0000-0002-5764-5788ISNI 0000000010971418
Candore, Gianmario
Uddin, M.J.ISNI 0000000507450319
Souverein, Patrick C.ORCID 0000-0002-7452-0477ISNI 0000000392263686
Ali, M.S.ISNI 0000000419508349
Belitser, S.ISNI 000000041942150X
Huerta, Consuelo
Groenwold, Rolf H.H.ISNI 0000000394374611
Alvarez, Yolanda
Slattery, Jim

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

Purpose: The purpose of this study is to evaluate the performance and validity of the case-crossover (CCO) and self-controlled case-series (SCCS) designs when studying the association between hip/femur fracture (HF) and antidepressant (AD) use in general practitioner databases. In addition, comparability with cohort and case-control designs is discussed. Methods: Adult patients with HF and who received an AD prescription during 2001-2009 were identified from UK's The Health Improvement Network (THIN) and the Dutch Mondriaan databases. AD exposure was classified into current, recent and past/non-use (reference). In the CCO, for each patient, a case moment (date of HF) and four prior control moments at -91, -182, -273 and -365days were defined. In SCCS, incidence of HF was compared between exposure states. Conditional logistic regression was used in the CCO and Poisson regression in the SCCS to compute odds ratios and incidence rate ratios, respectively. In CCO, we adjusted for time-varying co-medication and in SCCS for age. Results: Adjusted estimates for the effect of current AD exposure on HF were higher in the CCO (co-medication-adjusted odds ratio, THIN: 2.24, 95% confidence interval [CI]: 2.04-2.47; Mondriaan: 2.57, 95%CI [1.50, 4.43]) than in the SCCS (age-adjusted incidence rate ratio, THIN: 1.41, 95%CI [1.32, 1.49]; Mondriaan: 2.14, 95%CI [1.51, 3.03]). The latter were comparable with the traditional designs. Conclusion: Case-only designs confirmed the association between AD and HF. The CCO design violated assumptions in this study with regard to exchangeability and length of exposure, and transient effects on outcome. The SCCS seems to be an appropriate design for assessing AD-HF association.

Keywords

Antidepressant, Case-crossover, Case-only design, Hip/femur fracture, Methodology, Pharmacoepidemiology, Self-controlled case series, antidepressant agent, serotonin uptake inhibitor, tricyclic antidepressant agent, adult, age, aged, article, case control study, case study, cohort analysis, confidence interval, correlation analysis, data base, drug exposure, electronic medical record, evaluation study, female, femur fracture, hip fracture, human, incidence, logistic regression analysis, major clinical study, male, multicenter study, Netherlands, outcome assessment, pharmacoepidemiology, Poisson distribution, priority journal, regression analysis, risk assessment, study design, United Kingdom, validity, Taverne

Citation

De Groot, M C H, Candore, G, Uddin, J, Souverein, P, Ali, M S, Belitser, S, Huerta, C, Groenwold, R H H, Alvarez, Y, Slattery, J, Korevaar, J, Hoes, A W, Roes, K C B, de Boer, A, Douglas, I J, Schlienger, R G, Reynolds, R, Klungel, O H & Gardarsdottir, H 2016, 'Case-only designs for studying the association of antidepressants and hip or femur fracture', Pharmacoepidemiology and Drug Safety, vol. 25, no. Supplement S1, pp. 103-113. https://doi.org/10.1002/pds.3850